(1)
Khammas, I.; Ali Abdulhussain Kasim; Bassam Francis. Serum Levels of Advanced Oxidation Protein Products and Some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib. Iraqi Journal of Pharmaceutical Sciences 2025, 34 (2), 40-46. https://doi.org/10.31351/vol34iss2pp40-46.